Plain-English translation of NCT06466382 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
OV Precision is a Swiss trial testing whether a personalized treatment approach works better for people with newly diagnosed advanced ovarian cancer. Researchers will analyze your tumor's unique genetic and molecular characteristics to recommend the best drugs or experimental treatments specifically for you, rather than giving everyone the same standard chemotherapy. Half of participants will receive this personalized treatment plan, while the other half will receive standard chemotherapy.
About half of people with advanced ovarian cancer don't respond well to standard chemotherapy, and doctors currently have few good options to help them. This trial was created to give patients with tumors that are harder to treat a chance to receive a therapy tailored to their individual tumor's biology, potentially improving their chances of living longer.
You likely qualify if…
You likely don't qualify if…
If you are randomly assigned to the personalized treatment group, researchers will analyze a sample of your tumor to create a detailed molecular profile. A specialized team of cancer doctors will then use this profile to recommend the best treatment option for you specifically—which might include standard chemotherapy, experimental drugs, or a combination. If you are in the standard care group, you will receive traditional chemotherapy. In both groups, you will have regular visits with your cancer doctor to monitor how you're doing and assess your treatment response.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Switzerland